KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Boston Scientific (BSX) Other Operating Expenses (2016 - 2026)

Boston Scientific's Other Operating Expenses history spans 17 years, with the latest figure at $213.0 million for Q1 2026.

  • On a quarterly basis, Other Operating Expenses fell 10.5% to $213.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.2 billion, a 8.63% decrease, with the full-year FY2025 number at $1.2 billion, changed N/A from a year prior.
  • Other Operating Expenses hit $213.0 million in Q1 2026 for Boston Scientific, down from $435.0 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for BSX hit a ceiling of $500.0 million in Q2 2024 and a floor of -$22.0 million in Q4 2022.
  • Historically, Other Operating Expenses has averaged $264.4 million across 5 years, with a median of $246.5 million in 2023.
  • Biggest five-year swings in Other Operating Expenses: plummeted 173.33% in 2022 and later soared 1250.0% in 2023.
  • Tracing BSX's Other Operating Expenses over 5 years: stood at -$22.0 million in 2022, then soared by 1250.0% to $253.0 million in 2023, then skyrocketed by 42.69% to $361.0 million in 2024, then rose by 20.5% to $435.0 million in 2025, then plummeted by 51.03% to $213.0 million in 2026.
  • Business Quant data shows Other Operating Expenses for BSX at $213.0 million in Q1 2026, $435.0 million in Q4 2025, and $247.0 million in Q3 2025.